"What managers need to know about the emerging genetic revolution" is the title of an article in Business Horizons where the authors adopt an evolutionary perspective to understand the impact of the genetic revolution on firms regardless of industry. They present a tiered model of how the realms of matter, biology and human cognition and culture relate and how humans have shaped and then programmed each through technology. Building on this model, we provide a protocol for managers to consider the potential impacts of genetic programming on their organisations.
Chinese researchers summarise the limitation of current CRISPR-based diagnostics. Then, they elaborate in detail on how five different types of microfluidics improve the performance of current CRISPR-based assays. In addition, they overlook the future development of CRISPR-based microfluidic assays and their applications.